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ABSTRAK 
 
Neuropati periferi adalah berkait rapat dengan masalah kaki di kalangan penghidap di-
abetes melitus. Kajian ini bertujuan untuk mengenalpasti tahap neuropati dan faktor-
faktor risiko berkaitan dengan keadaan ini. Satu kajian hirisan lintang telah dijalankan di 
klinik-klinik ulangan Pusat Perubatan UKM (PPUKM) Malaysia, melibatkan 72 pesakit 
diabetes dan 19 pesakit kawalan.  Pesakit yang mempunyai kaki yang bermasalah dan 
telah mempunyai neuropati tidak dimasukkan dalam kajian. Pesakit kawalan dipilih dari 
mereka yang tidak mempunyai diabetes, boleh berjalan secara normal, tiada masalah 
dengan kaki serta menghadiri klinik sebagai peneman kepada pesakit. Kajian kuantitatif 
dilakukan menggunakan Semmes-Weinstein monofilamen. ‘Neuropathy Disability Score’ 
(NDS) digunakan untuk mengukur tahap neuropati diabetes. Ujian ‘Spearman rank’ dan 
‘Mann-whitney’ dijalankan bagi mengenalpasti hubungkait antara neuropati dan faktor-
faktor yang dikaji. Ujian ‘logistic regression’ dijalankan untuk mengenalpasti faktor risiko 
keadaan ini. Aras purata HbA1c pada pesakit ialah 8.6 + 4.1, dan purata NDS ialah 7.0 + 
6.0. Sejumlah 79.1% didapati mempunyai neuropati dalam berbagai tahap, dengan fak-
tor kalus kaki dikenalpasti berhubungkait dengan markah NDS yang tinggi. Faktor lanjut 
usia (p = 0.02), berat badan (p = 0.03), HbA1c (p = 0.005) dan jangkamasa menghidap 
diabetes (p = < 0.005) mempunyai hubungkait positif dengan NDS. Program penjagaan 
kaki yang teratur untuk pesakit diabetes perlu mengambil kira faktor kalus kaki, dengan 
keutamaan diberi kepada mereka yang mempunyai berat badan berlebihan dan telah 
lanjut usia. 
 
Kata kunci:  diabetes melitus, neuropati periferi, 'Neuropathy Disability Score (NDS)', 
'Semmens-Weinstein monofilamen(SWMF), kalus 
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ABSTRACT  
 
Peripheral neuropathy is highly associated with foot complications among diabetics. This 
study aimed to identify risk factors associated with the development of peripheral neuro-
pathy in diabetic patients and their association with degree of severity of peripheral neu-
ropathy. A cross-sectional study was conducted in follow-up clinics at the Universiti Ke-
bangsaan Malaysia Medical Centre (UKMMC), Malaysia involving 72 diabetic patients 
and 19 controls. Exclusion criteria were those with amputated limbs, gross foot deformity 
and existing peripheral neuropathy. Controls were non diabetics who walked normally, 
had no history of foot problem and attended the clinic as subjects’ companion. Quantita-
tive assessment of neuropathy was done using Semmes-Weinstein monofilament. Neu-
ropathy Disability Score (NDS) were used to quantify severity of diabetic neuropathy.  
Spearman’s Rank test and Mann-Whitney test were used to determine correlation be-
tween variables and their differences. Logistic regression analysis was used to deter-
mine risk factors associated with peripheral neuropathy. The mean HbA1c among di-
abetics was 8.6% + 4.1, and mean NDS was 7.0 + 6.0. A total of 79.1% demonstrated 
various level of neuropathy with presence of callus was associated with higher NDS 
scores. Older age (P=0.02), body weight (P=0.03), HbA1c (P=0.005) and duration of di-
abetes (P <0.005) showed positive correlation with NDS. Proper foot care program for 
diabetics should include recognition of the callus, with special emphasis given to those 
with heavier weight and increasing age. 
 
Key words:  diabetes mellitus, peripheral neuropathy, Neuropathy Disability Score 
(NDS), Semmes Weinstein monofilament (SWMF), callus 
 
 
INTRODUCTION 
 
The World Health Organization has de-
clared that the number of people with di-
abetes mellitus (DM) is rapidly increasing 
and has become of major public health con-
cern (King & Rewers 1991; WHO 1992). 
The number of diabetic patients in develop-
ing countries is expected to increase by 
more than two-folds from 84 million in 1995 
to 225 million in 2025 (Aboderin et al. 2002). 
In Malaysia, the prevalence of adult diabet-
ics has doubled over a 10-year period with 
the prevalence in 2006 reported as 14.9%, 
the highest among the Asian countries 
(NHMSIII 2006). 
Complications affecting the lower limbs 
are one of the most common manifesta-
tions of diabetes. Approximately 15% of 
those with diabetes will eventually suffer 
from foot ulceration during their lifetime 
(WHO 1992). It is well recognized that 
diabetic patients experience decreased 
sensation of their feet because of peri-
pheral neuropathy which is the result of a 
complex interplay between a number of 
factors such as limited joint mobility (LJM), 
altered foot pressures and level of gly-
caemic control (Boulton et al. 1983; 
Caputo et al. 1994; Reiber et al. 1999). 
The loss of sensation caused by poorly 
controlled diabetes is also thought to re-
duce the protective sensation of the foot. 
The repetitive trauma to the plantar areas 
increases the risks of foot ulceration, 
which may lead to foot amputation in se-
vere uncontrolled cases. 
Factors such as age, gender, diabetic 
control, presence of vascular disease, and 
extrinsic sources of trauma were theoreti-
cally reported to be associated with the 
development of peripheral neuropathy 
amongst diabetic patients (Adler et al. 
1997; Tesfaye et al. 1996). To date, there 
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is limited evidence regarding the risk fac-
tors for the development of peripheral 
neuropathy amongst diabetic patients. 
Hence, this study aimed to identify risk 
factors associated with the development 
of peripheral neuropathy in DM patients 
and their association with the severity of 
peripheral neuropathy amongst these pa-
tients. The results from this study will be 
beneficial for the health care providers to 
initiate early preventive measures to the 
patients. 
 
MATERIALS AND METHODS 
 
Design 
 
This was a cross-sectional study con-
ducted amongst patients diagnosed with 
DM attending outpatient clinics in UKM 
Medical Centre, Kuala Lumpur. The study 
was conducted from January to August 
2008, involving diabetic patients in three 
out-patient clinics i.e. primary care centre, 
medical endocrine clinic and orthopaedic 
clinic.  
 
Subjects  
 
All diabetic patients aged 18 to 70 years 
old attending the clinics were invited to 
participate in the study. Written consent 
was obtained before patients were sub-
jected to assessments for the study. The 
diagnosis of DM was established from re-
views of the patients’ medical records. 
Consented patients were given a checklist 
documenting duration of diabetes, medical 
co-morbidities, smoking habits and pres-
ence of foot ulceration. Patients were then 
examined for the presence of clinical peri-
pheral neuropathy. Exclusion criteria in-
cluded patients with limb amputation, gross 
foot deformity (e.g: Charcot joints, hallux 
valgus), and existing peripheral neuropathy 
in patients.  Controls were recruited from 
non-diabetes mellitus (NDM) subjects that 
were able to walk normally, had no history 
of foot problem and attending the clinic as 
the subjects’ accompaniment during the 
study period. 
 
Study instrument 
 
Neuropathy screening was performed us-
ing the Semmes-Weinstein monofilament 
(SWMF) 5.07/10g that was used as a 
quantitative assessment of the cutaneous 
pressure perception. With both eyes 
closed, the patient informed the investi-
gator when he or she could feel the fila-
ment applied to a non-callus site at 8 plan-
tar locations. Neuropathy was confirmed 
when more than half   responses were in-
correct (Perkins et al. 2001). The Neuro-
pathy Disability Score (NDS) was used to 
quantify the severity of the neuropathy.  
The Achilles tendon reflexes were ex-
amined: a score of zero (0) was given if the 
reflexes were normal, one (1) if the reflexes 
could be elicited with reinforcement and 
two (2) if the reflexes were absent.  Sen-
sory testing included pin prick using neuro-
tip, vibration using a biothesiometer with a 
cut-off value of 25 Volts to determine vibra-
tion perception and temperature testing 
using a cold tuning fork at the great toe: a 
score of zero (0) was given for each normal 
result and one (1) for each abnormal result. 
The summation of scores of each modality 
was entered as the NDS. A score of 1 and 
2 was considered normal, whereas score 
of 3 to 5 indicated mild peripheral neuro-
pathy, 6 to 8 indicated moderate peripheral 
neuropathy and 9 to 10 indicated severe 
neuropathy. Finally, the glycosylated hae-
moglobin (HbA1c) within the past six 
months was used to ascertain the level of 
glycaemic control of the patient. 
 
Statistical analysis 
 
Statistical analysis was conducted using 
the SPSS version 12.0. Descriptive analy-
sis was used for categorical data and 
analysis of mean, median and variance. 
The correlation of continuous variables 
and NDS were analyzed using Spear-
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man’s Rank order. For the correlation of 
categorical variables and NDS, Mann-
Whitney U test was used to determine the 
difference. Logistic regression analysis 
was applied to look for risk factors asso-
ciated with peripheral neuropathy. A p 
value of <0.05 was considered significant. 
 
RESULTS 
 
A total of 91 subjects (72 DM patients; 19 
NDM volunteers) were recruited. The 
demographic characteristics are shown 
in Table 1. For the DM group, 37.5% had 
DM for more than 15 years, 20.8% be-
tween 10 to 15 years, 20.9% between 5 
to 10 years while the remaining 20.8% 
less than five years. There were 49 
(41.7%) males. 
Among the DM patients, 79.1% demon-
strated various levels of peripheral neu-
ropathy (Table 1). Subjects with callus or 
ulcers had higher NDS than those without 
(Z: -2.36, p: 0.003). There was a positive 
correlation between the age of diabetic 
subjects and the NDS score (r: 0.36, N: 72, 
p: 0.02), with older DM subjects showing 
higher NDS. Weight of the DM subjects 
also demonstrated a positive correlation to 
the NDS (r: 0.35, N: 72, p: 0.03), with 
heavier diabetic subjects showing higher 
NDS. Although NDS seemed to have 
significant correlation with HbA1c (p: 0.005) 
and duration of diabetes (p<0.005), it was 
not significant in the logistic regression 
analysis. In contrast, NDS was not found to 
have an association with gender 
(P=0.179), ever smoked (P=0.351) and 
history of ulcer (P=0.189). 
Table 2 showed the logistic regression 
analysis of the risk factors associated with 
peripheral diabetic neuropathy. Age and 
weight were the only factors found to be 
significantly associated with peripheral 
neuropathy (age; p: 0.039; weight; p: 
0.005). 
 
DISCUSSION 
 
It is known that although a proportion of 
people with peripheral neuropathy 
present with pain and numbness, many 
are still asymptomatic until much later, 
hence it is imperative for physicians to 
identify those who are at risk to develop 
these complications. This study hig-
hlighted the fact that more than half of 
the DM cohorts demonstrated peripheral 
neuropathy, with age and body weight 
significantly associated with neuropathy. 
Our results confirm the well-established 
correlation between age and peripheral 
neuropathy. This finding could be attri-
buted to two main factors. First, the du-
ration of DM is acknowledged to be as-
sociated with the development of compli-
cations of diabetes, and peripheral neu-
ropathy is no exception. Secondly, the 
development of peripheral neuropathy is 
also known to increase with age, espe-
cially after the age of 65 in the general 
 
Table 1: Clinical characteristic of diabetes patients 
attending outpatient clinics PPUKM (n = 72) 
 
Characteristic Diabetes 
N = 72 
Percent 
(%) 
Age (years) 56.1±7.5 - 
   
Sex   
Male  30 41.7 
Female 42 58.3 
   
Weight (kg) 69.7±18.7 - 
   
HbA1c (%)  8.6±4.1 - 
Ever smoked  20 27.8 
NDS +7.0 ± 6.0 - 
   
Peripheral neuropathy 
(NDS Score) 
 
 
 
No evidence 15 20.8 
Mild 10 13.9 
Moderate 26 36.1 
Severe 21 29.2 
   
Presence of callus / ulcer 22 30.6 
+ Median ± interquartile range 
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Table 2: Logistic regression analysis of risk factors 
associated with diabetes peripheral neuropathy 
 
Variables OR 95% CI P value 
Age (year) 1.13 1.01-1.26 0.039 
    
Weight (kg) 1.10 1.03-1.18 0.005 
    
HbA1c (%) 0.206 0.89-1.69 0.206 
    
Duration of di-
abetes (years) 
   
< 5 years  1.0  
5 – 10 years 0.04 0.01-1.31 0.020 
10 – 15 years 0.20 0.02-1.26 0.870 
>15 years 0.37 0.05-2.63 0.318 
 
population with or without diabetes (Cho 
et al. 2006; Mold et al. 2004). However 
the mean age for our DM cohorts was 
much lower than what was reported by 
Cho and Mold (Cho et al. 2006; Mold et 
al. 2004). Taking into consideration the 
high level of HbA1c amongst our DM co-
horts, we postulated that the combination 
of age, duration of diabetes and the poor 
glycaemic control might have contributed 
to the accelerating occurrence of peri-
pheral neuropathy amongst our DM pa-
tients. 
Our findings also demonstrated that 
heavier patients were more likely to suf-
fer from severe neuropathy compared to 
those who were less heavy. This finding 
is consistent with other studies which 
showed that obese patients achieved 
poorer results in test of clinical neuropa-
thy compared to those who were less 
obese (Cavanagh et al. 1991; Straub et 
al. 1994). Further analysis showed that 
the amount of visceral fat was propor-
tionally related to the increase of overall 
insulin resistance. This could explain the 
findings of severe neuropathy in sub-
jects with heavier body weights. How-
ever, this finding was based on the 
weight alone not the body mass index 
(BMI) to give an accurate relationship 
between neuropathy and level of obesity 
amongst DM patients. 
Callus or hyperkeratosis has been im-
plicated in the etiology of neuropathic 
ulceration. Callus acts like a foreign body 
which in turn increases the likelihood for 
tissue breakdown and consequently for-
mation of an ulcer under the callus. Stu-
dies have shown that plantar calluses 
were a strong predictor for ulcers and 
ulcers recurred mainly at the site of cal-
luses (Murray et al. 1996; Menz et al. 
2007). In the present study, the presence 
of callus was found to be associated with 
higher NDS. This is important as simple 
measures like paring of the callus may 
reduce the risk of plantar ulceration 
(Young et al. 1992). The fact that cal-
luses were present in approximately 30% 
of the cohort, suggested that poor foot 
care was common among our patients 
and this warrants further intervention in 
both patients and health practitioners  
We were not able to demonstrate any 
associations of neuropathy with the male 
gender, ethnicity and duration of diabetes 
mellitus. Peripheral neuropathy was also 
not significantly related to smoking, but 
most of our patients were non-smokers. 
However it is known that smoking causes 
the arrest of blood flow in the peripheries 
which in turn causes tissue hypoxia and 
neural microvascular damage leading to 
the development of peripheral neuropa-
thy (Benbow et al. 1997). The glycaemic 
control was not independently associated 
with neuropathy; the reason may be the 
cross sectional design of this study and a 
single and latest HbA1c result is possibly 
a poor indicator of the overall diabetic 
control.  
This study provided information to 
practitioners in identifying potentially re-
versible factors contributing to the devel-
opment of peripheral neuropathy, namely 
the patient’s body weight and presence 
of callus. It supported the deemed im-
portance of weight reduction in Type 2 
diabetes patients in preventing progres-
sion of neuropathy and consequently the 
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costly complications of plantar ulceration 
and lower extremity amputation. This 
study also underlined the importance of 
implementing a proper foot care program 
especially for those who are heavier and 
older. Although these practices have 
already been recommended by many 
clinical guidelines, many practitioners fail 
to adhere to them and fail to identify 
those at risk of peripheral neuropathy. 
So, an increased awareness by primary 
care providers of the associated risk 
factors can lead to an early therapeutic 
intervention and prevention of later neu-
ropathic complications such as infection 
and foot ulcers, allowing a decrease in 
patient morbidity. 
 
CONCLUSION 
 
This study demonstrated that age and 
weight were the risk determinants for the 
development of peripheral neuropathy. 
The presence of calluses was also found 
to be associated with those with peri-
pheral neuropathy. Early detection of 
these risk factors should be incorporated 
into any program aiming to reduce di-
abetic foot complication as to reduce 
morbidity that is commonly associated 
with diabetes mellitus. However, the 
study is limited by its cross-sectional de-
sign, we were unable to assess the 
cause and effect of the study. Likewise, 
population drawn was from an outpatient 
setting in a university hospital which in 
turn causes selection bias in this study. 
Patients in our cohort might be substan-
tially different from a community-based 
outpatient setting as our out-patient clin-
ics are mainly referral-based; hence it 
might not be a true representative of the 
general population. Nonetheless, despite 
the limitations, this population-based sur-
vey was able to inform us regarding the 
diabetes foot problems in Malaysia, using 
inexpensive and simple assessments 
that can be replicated even in remote 
settings. 
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